
About Dapic Metropolis Healthcare Private Limited
Data last updated:
Dapic Metropolis Healthcare Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Metropolis Healthcare Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 08 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85320MH2018PTC304941.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Ameera Sushil Shah and Alangadan Kannan.
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Unit Nos. 409 To 416 Kohinoor City Mall Kirol Road Off Lbs Marg, Mumbai, Maharashtra, India – 400070.
As per the financials filed for FY 2025, the company reported a revenue of ₹84,620. For the same year it recorded a net loss of ₹27.38 Lakh and EBITDA of -₹26.38 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 51% over three years and 56% over five years.
The company has 1 deal on record (1 secondary share transfer); the latest was in August 2021.
For more details, the company can be reached via its website metropolisindia.com.
Company details
Contact details
Dapic Metropolis Healthcare Private Limited's registered office is in Mumbai, Maharashtra. Its website is metropolisindia.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Apps
- Registered Address4th Floor Unit Nos. 409 To 416 Kohinoor City Mall Kirol Road Off Lbs Marg, Mumbai, Maharashtra, India – 400070
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Dapic Metropolis Healthcare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dapic Metropolis Healthcare is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
Financials of Dapic Metropolis Healthcare Private Limited
FY 2025 filings availableDapic Metropolis Healthcare Private Limited reported revenue of ₹84,620 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 56% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹26.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹27.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dapic Metropolis Healthcare Private Limited, buy the company report.
Board of directors of Dapic Metropolis Healthcare Private Limited
Dapic Metropolis Healthcare has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ameera Sushil Shah | Director | 08 Feb 2018 | 8 Years 8 Months | Current |
| Alangadan Kannan Also directs: Centralab Healthcare Services Private Limited | Director | 23 May 2022 | 4 Years 5 Months | Current |
| Ishita Medhekar | Director | 23 May 2022 | 4 Years 5 Months | Current |
Auditor
Dapic Metropolis Healthcare Private Limited is audited by B S R & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2023 | 101248W/W-100022 |
Shareholding
The shareholding of Dapic Metropolis Healthcare Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dapic Metropolis Healthcare Private Limited, buy the company report.
Deals & funding
Dapic Metropolis Healthcare Private Limited has 1 deal on record (1 secondary share transfer); the latest was in August 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: Metropolis Healthcare Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Dapic Metropolis Healthcare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dapic Metropolis Healthcare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dapic Metropolis Healthcare Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dapic Metropolis Healthcare Private Limited has 8 board changes on record since 2018: 3 appointments and 5 cessations. The latest: Aparna Chetan Rajadhyaksha ceased to be Additional Director on 24 Sep 2024.
News
Frequently asked questions
Dapic Metropolis Healthcare is an active private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 08 February 2018 (8+ years old) and is registered under CIN U85320MH2018PTC304941.
Dapic Metropolis Healthcare has 3 current directors:
- Ameera Sushil Shah - Director
- Alangadan Kannan - Director
- Ishita Medhekar - Director
The latest financial statements of Dapic Metropolis Healthcare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Dapic Metropolis Healthcare is U85320MH2018PTC304941. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dapic Metropolis Healthcare was incorporated on 08 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Dapic Metropolis Healthcare has 1 deal on record (1 secondary share transfer); the latest was in August 2021.
Aparna Chetan Rajadhyaksha ceased to be Additional Director on 24 Sep 2024. Vijender Singh ceased to be Director on 17 Aug 2022. Alangadan Kannan ceased to be Additional Director on 16 Aug 2022. Dapic Metropolis Healthcare has 8 board changes on record in total.
Dapic Metropolis Healthcare can be reached through the website metropolisindia.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Dapic Metropolis Healthcare is at 4th Floor Unit Nos. 409 To 416 Kohinoor City Mall Kirol Road Off Lbs Marg, Mumbai, Maharashtra, India – 400070.
Dapic Metropolis Healthcare operates in the healthcare industry, in the diagnostic centers and pathology labs segment.

